DHRS2 and ocular melanoma: Both PHiD-CV and PCV-10 likely reduce all-cause OM, but there is not strong evidence that Protein D in this formulation reduces carriage of NTHi or OM disease caused by NTHi (de Sévaux et al., 2020; Beissbarth et al., 2021).